Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study For MoxDuo(TM) IV Pain Therapy
QRxPharma Limited (Pink Sheets: QRXPY; ASX: QRX) announced the initiation of a Phase 2 comparative proof-of-concept study to evaluate the efficacy and safety of MoxDuo(TM) IV (intravenous morphine and oxycodone) versus IV morphine alone for the treatment of moderate to severe post-operative pain in patients following hip replacement surgery. Data from this study will serve as a significant predictor of MoxDuo(TM) IV"s clinical benefits and provide guidance for the design of further clinical trials leading to submission of an NDA to the US Food and Drug Administration (FDA) within the next three years.
generic viagra online
Swine Flu And The Influenza Virus In 1918
The influenza virus that wreaked worldwide havoc in 1918-1919 founded a viral dynasty that persists to this day, according to scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. In an article published online on June 29 by the New England Journal of Medicine, authors Anthony S. Fauci, M.D., Jeffery K. Taubenberger, M.D., Ph.D., and David M. Morens, M.D., argue that we have lived in an influenza pandemic era since 1918, and they describe how the novel 2009 H1N1 virus now circling the globe is yet another manifestation of this enduring viral family.
News of the day
Stem Cell Study Seeks To Wean Non-Related Transplant Recipients From Anti-Rejection Drugs
The immunosuppressive drugs required by organ transplant recipients after surgery can have serious side effects with prolonged use, including infection, heart disease and cancer. In an effort to reduce, or potentially eliminate the need for anti-rejection medications, researchers at Northwestern Memorial Hospital and Northwestern University"s Feinberg School of Medicine are investigating the efficacy of a stem cell transplant after organ transplant. The study, which is the first to test the protocol on non-related living donor kidney pairs, involves transplanting stem cells from the kidney donor into the recipient one day following the organ transplant surgery.
Mental Health

New Guidelines To Standardise Access Criteria For IVF Treatment

The National Infertility Awareness Campaign (NIAC) welcomed the document "Standardising Access Criteria to NHS Fertility Treatment"1 produced by Infertility Network UK (I N UK) and funded by the Department of Health. The NICE Guideline issued in 2004 recommended that eligible couples should receive three full cycles of IVF or ICSI NHS treatment, and defines a cycle as one which includes frozen embryo transfers (FET), but more than five years on there remains considerable disparity not only in the number of cycles being funded by the Primary Care Trusts (PCTs) but equally importantly in the access criteria applied by the PCTs in determining who can receive treatment. Recent measures announced by the Government to encourage implementation of the Guideline have led to an improvement in the provision in some areas but more needs to be done by Primary Care Trusts in England to ensure that patients have equal and timely access to the full range of treatment recommended by NICE, and to tackle the ongoing variations in provision that exist across the country. Clare Lewis-Jones, Chair of NIAC and Chief Executive of Infertility Network UK said "Although there has been an improvement recently in the provision of treatment by some PCTs, there still remains considerable variation in the criteria used to determine whether or not couples can access treatment. We welcome the recent measures announced by the Government to encourage implementation of the Guideline but particularly with the move towards single embryo transfer (SET) more needs to be done by the PCTs to fund three full cycles as recommended in the NICE Guideline and to standardise the access criteria they use to determine who can access NHS treatment and allow couples to have the treatment they need to help them have their family. It is totally unacceptable that patients are denied treatment simply because of where they live or on the basis of their age, and we urge all PCTs to implement these new recommendations and make access to fertility services fair, consistent, cost effective and clinically effective across the country." 1 The document "Standardising Access Criteria to NHS Fertility Treatment" produced by Infertility Network UK can be accessed via the Infertility Network UK Website http://www.infertilitynetworkuk.com Infertility Network UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009